Our results indicated that GSK3B, a key effector within the PI3K‐Akt pathway, underwent a switch from compartment B to A and was upregulated in somatotroph tumour (Figure 2F, Log2FC 2.22, padj < .001; Table S4). The gene discussed is GSK3B; the disease is neoplasm.